tiprankstipranks
Trending News
More News >
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market
Advertisement

Lepu Biopharma Co. Ltd. Class H (2157) Price & Analysis

Compare
2 Followers

2157 Stock Chart & Stats


Lepu Biopharma Co. Ltd. Class H News

2157 FAQ

What was Lepu Biopharma Co. Ltd. Class H’s price range in the past 12 months?
Lepu Biopharma Co. Ltd. Class H lowest stock price was HK$2.16 and its highest was HK$10.20 in the past 12 months.
    What is Lepu Biopharma Co. Ltd. Class H’s market cap?
    Lepu Biopharma Co. Ltd. Class H’s market cap is HK$17.75B.
      When is Lepu Biopharma Co. Ltd. Class H’s upcoming earnings report date?
      Lepu Biopharma Co. Ltd. Class H’s upcoming earnings report date is Aug 20, 2025 which is in 12 days.
        How were Lepu Biopharma Co. Ltd. Class H’s earnings last quarter?
        Lepu Biopharma Co. Ltd. Class H released its earnings results on Mar 27, 2025. The company reported -HK$0.139 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.139.
          Is Lepu Biopharma Co. Ltd. Class H overvalued?
          According to Wall Street analysts Lepu Biopharma Co. Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Lepu Biopharma Co. Ltd. Class H pay dividends?
            Lepu Biopharma Co. Ltd. Class H does not currently pay dividends.
            What is Lepu Biopharma Co. Ltd. Class H’s EPS estimate?
            Lepu Biopharma Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Lepu Biopharma Co. Ltd. Class H have?
            Lepu Biopharma Co. Ltd. Class H has 1,804,439,800 shares outstanding.
              What happened to Lepu Biopharma Co. Ltd. Class H’s price movement after its last earnings report?
              Lepu Biopharma Co. Ltd. Class H reported an EPS of -HK$0.139 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.153%.
                Which hedge fund is a major shareholder of Lepu Biopharma Co. Ltd. Class H?
                Currently, no hedge funds are holding shares in HK:2157

                Lepu Biopharma Co. Ltd. Class H Stock Smart Score

                7
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                206.08%
                12-Months-Change

                Fundamentals

                Return on Equity
                -51.40%
                Trailing 12-Months
                Asset Growth
                -7.63%
                Trailing 12-Months

                Company Description

                Lepu Biopharma Co. Ltd. Class H

                Lepu Biopharma Co. Ltd. Class H (2157) is a biopharmaceutical company focused on the research, development, and commercialization of innovative oncology drugs. The company operates primarily in the biotechnology and pharmaceutical sectors, aiming to deliver high-quality healthcare solutions to address unmet medical needs in cancer treatment. Its product portfolio includes a range of targeted therapies and biological medicines designed to improve patient outcomes.

                Lepu Biopharma Co. Ltd. Class H (2157) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Ascletis Pharma, Inc.
                Keymed Biosciences, Inc.
                CARsgen Therapeutics Holdings Ltd.
                Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
                ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H

                Ownership Overview

                <0.01%99.23%
                Insiders
                <0.01%
                Mutual Funds
                ― Other Institutional Investors
                99.23% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis